Methichit Wattanapanitch

6PUBLICATIONS
3CO-AUTHORS
Molecular targetsGene and molecular therapyMedical devicesTissue engineeringRegenerative medicine (incl. stem cells)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jul 14, 2025
Enhancing macrophage phagocytosis of cancers by disrupting the SIRPα/CD47 signaling axis and targeting MUC1 antigen.

Saitong Muneekaew, Pasut Sasithong, Koollawat Chupradit

|Feb 13, 2025
Development of 2LTRZFP-expressing induced pluripotent stem cells as a potential anti-HIV-1 gene therapy against viral integration.

Kritayaporn Saiprayong, Koollawat Chupradit, Pasut Sasithong

|Dec 11, 2022
Validation of Promoters and Codon Optimization on CRISPR/Cas9-Engineered Jurkat Cells Stably Expressing αRep4E3 for Interfering with HIV-1 Replication.

Koollawat Chupradit, Kanokporn Sornsuwan, Kritayaporn Saiprayong

|Feb 26, 2022
Engineered Zinc Finger Protein Targeting 2LTR Inhibits HIV Integration in Hematopoietic Stem and Progenitor Cell-Derived Macrophages: In Vitro Study.

Koollawat Chupradit, Wannisa Khamaikawin, Supachai Sakkhachornphop

|Jan 24, 2022
Efficient generation of endothelial cells from induced pluripotent stem cells derived from a patient with peripheral arterial disease.

Bootsakorn Boonkaew, Siriwal Suwanpitak, Kovit Pattanapanyasat

|Jun 14, 2019
Recent Updates on Induced Pluripotent Stem Cells in Hematological Disorders.

Methichit Wattanapanitch

Pageof 1